-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

631.P1.43 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster I

Symposia: Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Alexandra Schurer, MS1,2, Lindsay Gurska, PhD1,2*, Yuxuan Wang1*, Allison Montoya1*, Swati Goel, MD3 and Kira Gritsman, MD, PhD1,4

1Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY
2The Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine, Albert Einstein College of Medicine, Bronx, NY
3Montefiore Einstein Comprehensive Cancer Center, Blood Cancer Institute, Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
4Albert Einstein College of Medicine, Bronx, NY

Julia Xu*, Brian MacDonald, MD*, John Quisel, PhD* and Min Wu, PhD

Disc Medicine Inc., Watertown, MA

Nikita Vantsev, BS1*, Liang Zhao, PhD1*, Charles S. Abrams, MD1 and Wei Tong, PhD2,3

1Department of Medicine, University of Pennsylvania, Philadelphia, PA
2Children's Hospital of Philadelphia, Philadelphia, PA
3Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

Ghazal Narimanfar, MSc1*, Dorian Forte, PhD1*, Roberto Maria Pellegrino2*, Francesca Perut, PhD3*, Filippo Maltoni, BSc1*, Martina Barone, PhD4*, Alessia Brancolini5*, Filippo Branzanti, MSc4*, Virginia Pucci6*, Elisabetta Lugli, MD6*, Alessia Tieghi, MD6*, Carla Emiliani, PhD2*, Regina Grillari, PhD5*, Pier Luigi Zinzani, MD1,4, Francesca Palandri, MD, PhD4* and Lucia Catani, PhD1,4*

1Institute of Hematology “L. e A. Seràgnoli”, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
2Department of Chemistry, Biology and Biotechnology, Biochemistry and Molecular Biology Section, University of Perugia, Perugia, Italy
3Biomedical Sciences and Technologies (BST), Biomedical Sciences and Technologies Lab, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
4IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
5Evercyte GmbH, Vienna, Austria
6Department of Hematology, Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy

Sarah Awan-Toor1*, Jimena Castorena2*, Denis Clay3*, Juliette Soret-Dulphy4,5*, Rafael Daltro De Oliveira5*, Ludovic Drouet6*, Hélène Pasquer, M.D.7*, Damien Luque-Paz, PharmD, PhD8*, Valerie Ugo9*, Emmanuelle Verger10*, Nabih Maslah, PharmD, PhD11,12*, Lina Benajiba, MD, PhD5,13, Stephane Giraudier1,12*, Jean-Jacques Kiladjian, MD, PhD1,4, Bruno Cassinat14,15 and Laura Velazquez, PhD2*

1INSERM UMR 1131, Institut de Recherche Saint-Louis, Paris, France
2INSERM UMRS-MD1197, Hôpital Paul Brousse, Villejuif, France
3INSERM UMS44, Hôpital Paul Brousse, Villejuif, France
4Clinical Investigation Center, Saint-Louis Hospital, Paris, France
5Hôpital Saint-Louis, Service d’Hématologie seniors, Centre d’Investigation Clinique, 14-27 Saint-Louis, France
6Hopital Lariboisière, PARIS, FRA
7INSERM UMR944, Institut de Recherche Saint-Louis, PARIS, FRA
8Université Angers, Nantes Université, CHU Angers, INSERM, CNRS, CRI2NA, Angers, France
9Université Angers, Nantes Université, CHU Angers, Inserm, CNRS, CRCI2NA, Angers, France
10Laboratoire de Biologie Cellulaire, Université Paris Cité, APHP, Hôpital Saint-Louis, Paris, FRA
11INSERM UMR 1131, Institut de Recherche Saint-Louis, Paris, FRA
12Laboratoire de Biologie Cellulaire, Université Paris Cité, APHP, Hôpital Saint-Louis, Paris, France
13INSERM UMR944, Institut de Recherche Saint-Louis, Paris, France
14INSERM UMR 1131, Saint-Louis Research Institut, Paris, France
15Cellular biology departement, Saint-Louis Hospital, Paris, France

Camila Araújo Bernardino Garcia, PhD1*, Larissa Sarri Binelli2*, Leonardo Carvalho Palma3,4, Leticia Olops Marani5*, Mariana Medeiros1,2*, Allana Guimarães de Carvalho2,5*, Priscila Santos Scheucher6*, Josiane Lillian Schiavinato1*, Pedro Manoel Marques Garibaldi5*, Robert Welner, PhD7,8, Fabíola Attié de Castro9*, Katia B Pagnano, MD, PhD10,11 and Lorena Lobo Figueiredo-Pontes, MD, PhD12,13

1Division of Hematology, Hemotherapy, and Cellular Therapy, Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeirao Preto Medical School, University of Sao Paulo (FMRP-USP), Ribeirao Preto, SP, Brazil., Ribeirão Preto, Brazil
2Ribeirão Preto Blood Center Foundation - University of São Paulo, Ribeirão Preto, Brazil
3Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil
4Department of Medical Images, Hematology and Clinical Oncology, Hematology division, Ribeirao Preto, Brazil
5Hematology Division, Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeirao Preto Medical School at University of Sao Paulo, Ribeirao Preto, Brazil, Ribeirão Preto, Brazil
6Division of Hematology, Hemotherapy, and Cellular Therapy, Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeirao Preto Medical School, University of Sao Paulo (FMRP-USP), Ribeirao Preto, SP, Brazil., Ribeirao Preto, BRA
7Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA, Birmingham, AL
8Division of Hematology and Oncology, Department of Medicine, UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
9Department of Clinical Analysis, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil, Ribeirão Preto, Brazil
10Centro de Hematologia e Hemoterapia (HEMOCENTRO), Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
11Hematology and Transfusion Medicine Center - University of Campinas/Hemocentro- Unicamp, Campinas, Sao Paulo, Brazil, Campinas, Brazil
12Hematology Division, Department of Medical Images, Hematology, and Clinical Oncology, University of Sao Paulo at Ribeirao Preto Medical School, Ribeirao Preto, Sao Paulo, Brazil
13Regional Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil, Ribeirão Preto, Brazil

Hongzhe Li, PhD1*, Alba Sierras, BS1*, Anne Hultquist, MD, PhD1,2* and Stefan Scheding, MD1,3

1Division of Molecular Hematology and Stem Cell Center, Lund University, Lund, Sweden
2Laboratory Medicine Skane, Department of Clinical Pathology, Lund, Sweden
3Hematology, Skane University Hospital, Lund, Sweden

Jihyun Song, PhD, Soo Jin Kim, MS*, Grace Min*, Yewon Lim* and Josef T. Prchal, MD

Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

Eli M Soyfer, MS1, Jianhong C Heidmann, BS2*, Helen Huang3*, Yeowon Jung2*, Eshika Arora2*, Lauren Chen2*, Aanya Amin2*, Anaya Qamar4* and Angela G. Fleischman, MD, PhD5

1Medicine, Biological Chemistry, University of California, Irvine, Irvine, CA
2University of California, Irvine, Irvine, CA
3Division of Hematology/Oncology, University of California, Irvine, New Taipei, Taiwan
4University of California, Irvine, Irvine
5Division of Hematology/Oncology, University of California, Irvine, Irvine, CA

Ivo Veletic, MD1*, Taghi Manshouri, PhD1*, C. Cameron Yin, MD, PhD2, Christopher D. Pacheco, BS1*, Christopher P. Ly, MS1*, Enes Dasdemir1*, Evan N. Cohen, PhD3*, Lucia Masarova, MD1, Naveen Pemmaraju, MD1, Prithviraj Bose, MD1, Hagop M. Kantarjian, MD1, Zeev Estrov, MD1, Patrick K. Reville, MD, MPH1, Andrew Dunbar, MD4 and Hussein A. Abbas, MD, PhD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX

Franco Castillo Tokumori, MD1,2, Daniel C Choi, MD3,4, Ghaith Abu-Zeinah, MD3,4, Nassima Messali, PhD4, Maria Mia Yabut, MS4* and Joseph M. Scandura, MD, PhD3

1Weill Cornell Medical College, New York, NY
2New York Presbyterian Hospital - Weill Cornell Medical College, New York, NY
3Richard T. Silver, MD Myeloproliferative Neoplasms Center, Weill Cornell Medicine, New York, NY
4Weill Cornell Medicine, New York, NY

Idan Goldberg, MD1,2,3*, Shirly Partouche, PhD4*, Erez Halperin, MD1,2*, Bahaa Atamna, MD5,6*, Adi Shacham Abulafia, MD1,2*, Saar Shapira, MMSc4*, Aladin Samara, BSc, MSc4*, Ayala Gover-Proaktor, PhD4*, Avi Leader, MD7,8, Galia Spectre, MD, PhD1,2*, Pia Raanani, MD9,10, Galit Granot, PhD2,4* and Ofir Wolach, MD1,2*

1Rabin Medical Center, Institute of Hematology, Petah Tikva, Israel
2Tel Aviv University, The Faculty of Medicine & Health Sciences, Tel Aviv, Israel
3Beilinson Hospital, Rabin Medical Center, Department of Internal Medicine F – Recanati, Petah Tikva, Israel
4Rabin Medical Center, Felsenstein Medical Research Center, Petah Tikva, Israel
5Rabin Medical Center, Institute of Hematology, Kfar Qara, Israel
6Tel Aviv University, The Faculty of Medicine & Health Sciences, Tel Aviv University, Tel Aviv, Israel
7Hematology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
8Weill Cornell Medical College, New York, NY
9Tel Aviv University, The Faculty of Medicine and Health Sciences, Tel Aviv, Israel
10Davidoff Cancer Center, Rabin Medical Center, Institute of Hematology, Petah Tikva, Israel

Luca Di Marino1*, Francesco Ramundo2*, Tanja Malara, MD3*, Monica Rossi, MD4*, Roberto Maggi, MD5*, Federica Fosso6*, Silvia Betti7*, Elena Rossi, MD8*, Giuseppe Leone, Prof9, Simona Sica, MD, PhD10*, Valerio De Stefano, MD8* and Patrizia Chiusolo, MD, PhD11*

1Dipartimento di Scienze di Laboratorio ed Ematologiche-Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Roma, Italy
2Institute of Hematology, Catholic University School of Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Roma, Italy
3Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
4Dipartimento di Scienze di Laboratorio ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
5Dipartimento di Scienze di Laboratorio ed Ematologiche-Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, AL, ITA
6Dipartimento di Scienze di Laboratorio ed Ematologiche-Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, ITA
7Ematologia Universita Cattolica Sacro Cuore, Roma, Italy
8Fondazione Policlinico Gemelli IRCCS, Section of Hematology, Catholic University, Rome, Roma, Italy
9Catholic University of Sacred Heart, Roma, RM, ITA
10Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
11UOC Ematologia e Trapianto Cellule Staminali Emopoietiche, Fondazione Policlinico Universitario A. Gemelli IRCCS Roma, Rome, Italy

Daniel C Choi, MD1, Nassima Messali, PhD2, Ghaith Abu-Zeinah, MD1,2, Pouneh Kermani, PhD2*, Maria Mia Yabut, MS2*, Franco Castillo Tokumori, MD1,3, Katie Erdos1*, Joseph M. Scandura, MD, PhD1,2, Narasimha Rao Uda, PhD4*, Heidi Lischer, PhD5*, Thomas Lehmann, MD4*, Marta Sobas, MD6* and Tata Nageswara Rao, PhD4,7*

1Richard T. Silver, MD Myeloproliferative Neoplasms Center, Weill Cornell Medicine, New York, NY
2Weill Cornell Medicine, New York, NY
3New York Presbyterian Hospital - Weill Cornell Medical College, New York, NY
4Department of Oncology and Hematology, Medical Research Center, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
5Interfaculty Bioinformatics Unit and Swiss Institute of Bioinformatics, University of Bern, Bern,, Switzerland
6Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Medical University of Wroclaw, Wroclaw, Poland
7Institute for Pharmacology, University of Bern, Bern, Switzerland

*signifies non-member of ASH